The Role of the Adenosinergic Pathway in the Resistance to Hypomethylating Agents
George Vrachiolias(Democritus University of Thrace), Ιoannis Kotsianidis(Democritus University of Thrace), Chrysa Kymparidou(Democritus University of Thrace), Elsa Bernard(Inserm), Menelaos Papoutselis(Democritus University of Thrace), Paul Costeas(Deakin University), Despoina Dimitriou(Democritus University of Thrace), Athanasios Tasis(Democritus University of Thrace), Christina Misidou(Democritus University of Thrace), Konstantinos Liapis(Democritus University of Thrace), Ioannis Mitroulis(Democritus University of Thrace), Eleftheria Lamprianidou(Democritus University of Thrace), Theodoros Spyropoulos(Democritus University of Thrace), Elli Papaemmanuil
Cited by 0
Related Papers
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family
|Journal of Bacteriology|1992|586